VERACYTE, INC.·4

Nov 7, 4:10 PM ET

Chambers Rebecca 4

4 · VERACYTE, INC. · Filed Nov 7, 2025

Insider Transaction Report

Form 4
Period: 2025-11-05
Chambers Rebecca
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2025-11-05$41.00/sh7,000$287,000126,158 total
Footnotes (1)
  • [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 13, 2024.

Documents

1 file
  • 4
    wk-form4_1762549809.xmlPrimary

    FORM 4